Page 1 of 65
NR 566 FINAL EXAM PREP 2026 QUESTIONS WITH VERIFIED ANSWERS DETAILED
RATIONALES GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics (Questions 1-25)
1. A drug with a narrow therapeutic index (TI) requires which type of
monitoring?
A. No monitoring is needed
B. Therapeutic drug monitoring to maintain levels within a narrow range
C. Only renal function monitoring
D. Only liver function monitoring
Rationale: Drugs with a narrow therapeutic index have a small margin between
therapeutic and toxic doses. Monitoring ensures the drug level stays within the
therapeutic range to maximize benefit and minimize toxicity. Examples include
warfarin, digoxin, and phenytoin.
2. A patient is receiving IV gentamicin. When should the nurse obtain the peak
serum level?
A. 30 minutes after the dose is administered
B. Immediately before giving the next dose
C. 60 minutes after the dose is administered
D. 90 minutes after the dose is administered
Rationale: Peak drug serum levels are achieved 30 minutes after the IV
administration of aminoglycosides. Trough levels are obtained immediately before
the next dose.
1|Page
,Page 2 of 65
3. Which physiologic mechanism explains a drug's increased metabolism that is
triggered by a disease process?
A. Selectivity response
B. Pharmacokinetics
C. Pharmacodynamics
D. Pharmacotherapeutics
Rationale: Pharmacokinetics describes the physiologic process of a drug's
movement throughout the body and how the drug's interaction is affected by an
underlying disease.
4. An older client is receiving a water-soluble drug at a dose higher than the
average for a young adult. Which action should the nurse implement first?
A. Obtain a prescription for lower medication dosages
B. Determine the drug's serum levels for toxicity
C. Start IV fluids to decrease the serum drug levels
D. Hold the next dosage and notify the health care provider
Rationale: Older clients typically have a decline in lean body mass and total body
water, causing water-soluble drugs to become distributed in fluid compartments,
resulting in increased concentration. Determining the drug's serum level for
toxicity should be implemented first.
5. Which factor most significantly affects drug absorption in older adults?
A. Increased gastric pH
B. Decreased intestinal blood flow
C. Reduced gastric emptying time
D. All of the above
2|Page
,Page 3 of 65
Rationale: All of these factors—increased gastric pH, decreased intestinal blood
flow, and reduced gastric emptying time—contribute to altered drug absorption in
older adults.
6. The volume of distribution (Vd) of a drug is 500 L with a clearance of 50 L/hr.
The elimination half-life is approximately:
A. 5 hours
B. 7 hours
C. 10 hours
D. 14 hours
Rationale: Half-life (t½) = (0.693 × Vd) / Clearance. t½ = (0.693 × 500) / 50 = 6.93
hours, approximately 7 hours.
7. Which statement about drug-drug interactions is correct?
A. All drug interactions are harmful
B. CYP450 enzyme induction increases drug metabolism
C. CYP450 enzyme inhibition increases drug metabolism
D. Protein binding displacement always causes toxicity
Rationale: CYP450 enzyme induction increases the metabolism of other drugs,
potentially decreasing their therapeutic effect.
8. A patient with hepatic impairment is prescribed a medication that undergoes
extensive first-pass metabolism. The provider should:
A. Increase the dose
B. Decrease the dose
C. Use the same dose
D. Use a parenteral route
3|Page
, Page 4 of 65
Rationale: Using a parenteral route bypasses the first-pass effect, which is
important when hepatic impairment reduces the metabolism of orally
administered drugs.
9. Which laboratory value is most important to monitor in a patient receiving an
aminoglycoside?
A. Serum creatinine and BUN
B. Complete blood count
C. Liver function tests
D. Serum potassium
Rationale: Aminoglycosides are nephrotoxic, so monitoring renal function (serum
creatinine and BUN) is essential.
10. Which process describes what the body does to a drug, including absorption,
distribution, metabolism, and excretion?
A. Pharmacodynamics
B. Pharmacogenetics
C. Pharmacokinetics
D. Pharmacotherapeutics
Rationale: Pharmacokinetics (PK) refers to the movement of a drug through the
body (what the body does to the drug).
11. A patient with a low serum albumin level is prescribed a highly protein-
bound drug. What is the main concern for this patient?
A. Rapid renal excretion
B. Decreased therapeutic effect
C. Increased risk of drug toxicity
D. Reduced drug absorption
4|Page
NR 566 FINAL EXAM PREP 2026 QUESTIONS WITH VERIFIED ANSWERS DETAILED
RATIONALES GRADED A+
Section 1: Pharmacokinetics & Pharmacodynamics (Questions 1-25)
1. A drug with a narrow therapeutic index (TI) requires which type of
monitoring?
A. No monitoring is needed
B. Therapeutic drug monitoring to maintain levels within a narrow range
C. Only renal function monitoring
D. Only liver function monitoring
Rationale: Drugs with a narrow therapeutic index have a small margin between
therapeutic and toxic doses. Monitoring ensures the drug level stays within the
therapeutic range to maximize benefit and minimize toxicity. Examples include
warfarin, digoxin, and phenytoin.
2. A patient is receiving IV gentamicin. When should the nurse obtain the peak
serum level?
A. 30 minutes after the dose is administered
B. Immediately before giving the next dose
C. 60 minutes after the dose is administered
D. 90 minutes after the dose is administered
Rationale: Peak drug serum levels are achieved 30 minutes after the IV
administration of aminoglycosides. Trough levels are obtained immediately before
the next dose.
1|Page
,Page 2 of 65
3. Which physiologic mechanism explains a drug's increased metabolism that is
triggered by a disease process?
A. Selectivity response
B. Pharmacokinetics
C. Pharmacodynamics
D. Pharmacotherapeutics
Rationale: Pharmacokinetics describes the physiologic process of a drug's
movement throughout the body and how the drug's interaction is affected by an
underlying disease.
4. An older client is receiving a water-soluble drug at a dose higher than the
average for a young adult. Which action should the nurse implement first?
A. Obtain a prescription for lower medication dosages
B. Determine the drug's serum levels for toxicity
C. Start IV fluids to decrease the serum drug levels
D. Hold the next dosage and notify the health care provider
Rationale: Older clients typically have a decline in lean body mass and total body
water, causing water-soluble drugs to become distributed in fluid compartments,
resulting in increased concentration. Determining the drug's serum level for
toxicity should be implemented first.
5. Which factor most significantly affects drug absorption in older adults?
A. Increased gastric pH
B. Decreased intestinal blood flow
C. Reduced gastric emptying time
D. All of the above
2|Page
,Page 3 of 65
Rationale: All of these factors—increased gastric pH, decreased intestinal blood
flow, and reduced gastric emptying time—contribute to altered drug absorption in
older adults.
6. The volume of distribution (Vd) of a drug is 500 L with a clearance of 50 L/hr.
The elimination half-life is approximately:
A. 5 hours
B. 7 hours
C. 10 hours
D. 14 hours
Rationale: Half-life (t½) = (0.693 × Vd) / Clearance. t½ = (0.693 × 500) / 50 = 6.93
hours, approximately 7 hours.
7. Which statement about drug-drug interactions is correct?
A. All drug interactions are harmful
B. CYP450 enzyme induction increases drug metabolism
C. CYP450 enzyme inhibition increases drug metabolism
D. Protein binding displacement always causes toxicity
Rationale: CYP450 enzyme induction increases the metabolism of other drugs,
potentially decreasing their therapeutic effect.
8. A patient with hepatic impairment is prescribed a medication that undergoes
extensive first-pass metabolism. The provider should:
A. Increase the dose
B. Decrease the dose
C. Use the same dose
D. Use a parenteral route
3|Page
, Page 4 of 65
Rationale: Using a parenteral route bypasses the first-pass effect, which is
important when hepatic impairment reduces the metabolism of orally
administered drugs.
9. Which laboratory value is most important to monitor in a patient receiving an
aminoglycoside?
A. Serum creatinine and BUN
B. Complete blood count
C. Liver function tests
D. Serum potassium
Rationale: Aminoglycosides are nephrotoxic, so monitoring renal function (serum
creatinine and BUN) is essential.
10. Which process describes what the body does to a drug, including absorption,
distribution, metabolism, and excretion?
A. Pharmacodynamics
B. Pharmacogenetics
C. Pharmacokinetics
D. Pharmacotherapeutics
Rationale: Pharmacokinetics (PK) refers to the movement of a drug through the
body (what the body does to the drug).
11. A patient with a low serum albumin level is prescribed a highly protein-
bound drug. What is the main concern for this patient?
A. Rapid renal excretion
B. Decreased therapeutic effect
C. Increased risk of drug toxicity
D. Reduced drug absorption
4|Page
